92例类风湿关节炎患者血脂分析(2)
 |
| 第1页 |
参见附件(2645KB，2页)。
综上所述，RA患者存在与疾病活动相关的脂质谱异常，应重视RA患者血脂的监测与管理，以减少心血管疾病的发生。
参考文献
[1] Michael T.Cardiovascular risk in rheumatoid arthritis[J].Autoimmunity Reviews,2009,8(8):639-716
[2] García-Gómez C,Nolla JM,Valverde J,et al.Conventional lipid profile and lipoprotein(a)concentrations in treated patients with rheumatoid arthritis[J].J Rheumatol,2009,36(7):1365-1370
[3] Rantap-Dahlqvist S,W llberg-Jonsson S,and Dahlén G.Lipoprotein (a),lipids,and lipoproteins in patients with Ann Rheum Dis,1991,50(6):366-368
[4] Garcês S P,Parreira Santos M J,Vinagre F M R,et al.Anti-tumour necrosis factor agents and lipid profile:a class effect[J].Ann Rhuem Dis,2008,67(6):895-896
[5] LjungL,Olsson,TEngstrand,S et al.Interleukin-1 receptor antagonist is associated with both lipid metabolism and inflammation in rheumatoid
arthritis[J].Clinical and experimental rheumatology,2007,25(4):617-620
[6] Hashizume M,Yoshida H,Koike N,et al.Over-produced IL-6decreases blood lipid levels via up-regulation of VLDLR[J].Ann Rheum Dis,2010,69(4):741-746
[7] Popa C,Netea MG,Radstake T,et al.Influence of anti-TNF therapy on the cardiovascular risk factors in patients with activerheumatoid arthritis[J].Ann Rheum Dis,2005,64(8):303-305
[8] Park YB,Choi HK,Kim MY,et al.Effects of antirheumatic therspy on serum lipid levels in patients with rheumatoid arthritis:a prospective study[J].Am J Med,2002,113(3):188-193
[9] Angelo M.Lp(a)as a cardiovascular risk factor[J].Journal of Molecular and Cellular Cardiology,1991,23:35.
您现在查看是摘要介绍页，详见PDF附件(2645KB，2页)。